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Abstract
Intake of the plant-derived n-3 fatty acid α-linolenic acid (ALA) has been associated with anti-atherosclerotic properties. However, information
on the association between ALA intake and development of peripheral artery disease (PAD) is lacking. In this follow-up study, we investigated
the association between dietary intake of ALA and the rate of PAD among middle-aged Danish men and women enrolled into the Danish Diet,
Cancer and Health cohort between 1993 and 1997. Incident PAD cases were identified through the Danish National Patient Register. Intake of
ALA was assessed using a validated FFQ. Statistical analyses were performed using Cox proportional hazard regression allowing for separate
baseline hazards among sexes and adjusted for established risk factors for PAD. During a median of 13·6 years of follow-up, we identified 950
valid cases of PAD with complete information on covariates. The median energy-adjusted ALA intake within the cohort was 1·76 g/d (95 %
central range: 0·94–3·28). In multivariable analyses, we found no statistically significant association between intake of ALA and the rate of
PAD (P= 0·339). Also, no statistically significant associations were observed in analyses including additional adjustment for co-morbidities
and in sex-specific analyses. In supplemental analyses with additional adjustment for potential dietary risk factors, we found a weak inverse
association of PAD with ALA intake above the median, but the association was not statistically significant (P= 0·314). In conclusion, dietary
intake of ALA was not consistently associated with decreased risk of PAD.
Key words: α-Linolenic acid: n-3 Fatty acids: Peripheral artery disease: Cohort studies
Peripheral artery disease (PAD) in the lower extremities is a
chronic atherosclerotic disease characterised by stenosis and
occlusion of the arteries, covering a clinical spectrum from no
symptoms to effort-induced ischaemicmuscle discomfort and/or
pain and critical ischaemia with tissue loss(1–3). Symptomatic
PAD is associated with functional limitations, diminished quality
of life and a high risk for major cardiovascular events and
death(4,5). The global burden of PAD is expected to increase
markedly in the near future and identification of factors that
may lower disease risk is urged(6).
The plant-derived n-3 fatty acid α-linolenic acid (ALA) is a
precursor of long-chain (LC) n-3 PUFA, which may influence
inflammatory processes that may be involved in development
and progression of atherosclerosis(7–9). However, the conversion
Abbreviations: ALA, α-linolenic acid; LC, long-chain; PAD, peripheral artery disease.
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capacity of ALA into LC n-3 PUFA may be limited in humans(10).
ALA may possibly exert health benefits independent of its pre-
cursor role(11) and has been suggested to be an important
nutrient in the Mediterranean diet(12), which has ascribed many
health benefits including lowering risk of PAD(13) and major
cardiovascular events(14).
The majority of previous follow-up studies investigating the
association between ALA intake and the risk of atherosclerotic
CVD have focused on CHD. Some cohort studies have reported
inverse associations between ALA intake and CHD risk(15–20), but
the results were not consistent(18,21–27). Few studies have
investigated associations between ALA intake and the risk of
ischaemic stroke(22,23,28–30), but to our knowledge no previous
follow-up studies have investigated the association between
ALA intake and the risk of PAD.
The objective of the present studywas to investigate the asso-
ciation between intake of ALA and the risk of PAD. We hypoth-
esised that intake of ALA would be inversely associated with the
risk of incident PAD.
Methods
Study population and design
This follow-up study was based on data from the Diet, Cancer
and Health cohort that was established to investigate the role
of diet and lifestyle in relation to cancer and other chronic dis-
eases(31). The recruitment procedures, sample size considera-
tions and collection of data have been described in detail
elsewhere(31). Briefly, native citizens aged 50–64 years whowere
living in and around Copenhagen and Aarhus in Denmark with-
out a previous diagnosis of cancer were invited between 1993
and 1997 to participate in the study. Potential eligible partici-
pants were identified through the Danish Civil Registration
System inwhich every citizen living in Denmark is providedwith
a unique identification number(31).
The Diet, Cancer and Health cohort study was conducted
according to the guidelines laid down in the Declaration of
Helsinki and approved by the Health Research Ethics, Capital
Region of Denmark, and the Danish Data Protection Agency.
All participants gave written informed consent at inclusion(31).
In the present follow-up study, participants registered with a
diagnosis of cancer not registered in the Danish Cancer Registry
at the time of invitation due to processing delay as well as par-
ticipants registered with a diagnosis of PAD or chronic kidney
disease before enrolment were excluded. Also, participants for
whom information on exposure and/or covariates was missing
were excluded. The current study has been approved by the
Danish Data Protection Agency (2008-58-0028-2016-229).
Exposure assessment
Information on habitual diet over the past 12 months was
assessed at baseline using a 192-item semi-quantitative FFQ(32).
The average consumption of foods and beverages was reported
within twelve categories ranging from never to eight or more
times per day. The reported intakes were used to estimate daily
intake of ALA and total energy based on Danish food composi-
tion tables (version 1.3.2) with the use of the software program
FoodCalc (Center for Applied Computer Science, University of
Copenhagen; www.ibt.ku.dk/jesper/foodcalc). The FFQ used
has previously been validated against two 7-d diet weighed
records and found useful for categorising individuals according
to their intake of energy and polyunsaturated fat(33). The intake
of ALA was expressed as energy-adjusted intake in g/d using the
residual method(34).
Covariates
Detailed information on social, lifestyle and health aspects such
as length of schooling, smoking habits, physical activity, history
of hypercholesterolaemia, hypertension and diabetes, and use of
lipid-lowering or anti-hypertensive agents and insulin were
collected at baseline using a self-administered questionnaire.
The questionnaire was processed by optical scanning and
checked for reading errors and omissions at the two study
centres where anthropometric measurements including height,
weight and waist circumference were also obtained at enrol-
ment. Information on alcohol consumption, total energy intake
and intake of other nutrients were obtained from the FFQ.
Outcome assessment
Incident cases of PAD were identified through record linkage
with the Danish National Patient Register, which includes infor-
mation on outpatient visits and discharge diagnoses from all hos-
pitals in Denmark(35,36).
Potential cases of PAD included participants registered
with either a primary or secondary discharge diagnosis of PAD
according to the International Classification of Diseases codes
(International Classification of Diseases-8: 44390; 44500; 44509;
44590; 44599; 44020 and 44030, and International Classification
of Diseases-10: I70.2, I70.2A and I73.9A-C). Subsequently, all
potential cases of PAD were validated by review of medical
records(37). A registered diagnosis of PAD was considered as
valid in patients with an ankle brachial index< 0·9, a toe brachial
index < 0·7 and/or demonstration of radiologically significant
stenosis or calcifications in relevant arteries in the lower extrem-
ities. Patients with an ankle brachial index > 1·4 together with a
history of diabetes mellitus or treatment by chronic renal dialysis
were also considered valid PAD cases. Furthermore, patients
who experienced a blood pressure drop in the lower extremities
of more than 30 mmHg or a 20 % drop of the resting ankle bra-
chial index immediately after a treadmill test and patients who
underwent relevant vascular surgery for atherosclerosis were
included as cases. Finally, patients who qualified for vascular
surgery for atherosclerosis although not performed due to severe
comorbidity were also included as cases(37).
Participants were followed up from baseline until first
registration of PAD, death, emigration or end of follow-up in
December 2009.
Statistics
Hazard ratios were used to describe associations between
energy-adjusted ALA intake and the rate of PAD. Hazard ratios
with 95 % CI were calculated using Cox proportional hazard
regression with age as underlying timescale allowing for sepa-
rate baseline hazards among men and women.
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Dietary intake of ALAwas analysed as a continuous exposure
variable using restricted cubic splines with three knots with the
median intake as reference in order to visualise the shape of the
observed associations. The knots were placed at the 10th, 50th
and 90th percentile as recommended by Harrell(38). The spline
curves were formally tested against a horizontal line using
Wald tests. The spline plots were restricted to the 95 % central
range and presentedwith 95 %CI. Also, analyseswith ALA intake
divided into quintiles were conducted using the lowest quintile
as reference.
We investigated the association between ALA intake and rate
of PAD in three different models specified prior to data analysis.
In model 1A, we included baseline age (continuous, years) in
order to ensure comparison of participants for whom reported
exposure information was of the same age. In model 1B, we
additionally included information on established risk factors
for PAD including length of schooling (≤7, 8–10 or >10 years),
smoking (never, former, current 1–14, 15–24 or >24 g/d), physi-
cal activity (inactive, moderately inactive, moderately active or
active), waist-circumference (continuous, cm), BMI (continuous,
kg/m2) and alcohol intake (continuous, g/d). In model 2,
we included the following co-morbidities, which may be consid-
ered potential intermediate variables: self-reported history of
hypercholesterolaemia and/or use of lipid-lowering medication
(yes, no or unknown), hypertension and/or use of anti-
hypertensive medication (yes, no or unknown) and diabetes
mellitus and/or use of insulin.
The proportional hazard assumption was evaluated by plot-
ting the scaled Schoenfeld residuals against age at event.
In sensitivity analyses, we plotted the whole exposure range
and examined whether the spline curves were robust when the
number and location of the knots were modified. Also, additional
adjustment for a history of myocardial infarction, ischaemic stroke
or both prior to enrolment was undertaken as sensitivity analyses.
In supplemental analyses, we investigated the association
between ALA intake and the rate of PAD in sex-specific analy-
ses. Also, analyses including adjustment for established risk fac-
tors (model 1B) and hormone substitution were undertaken. In
further supplemental analyses, potential dietary risk factors
were added to model 1B including total energy intake without
contribution from alcohol intake (continuous, kJ/d), intake of
fibre (continuous, g/d), glycaemic load (continuous, unit-less),
and intakes of SFA, MUFA, linoleic acid and marine LC n-3 PUFA
(continuous, g/d) (model 3). All continuous covariates were
entered into the models using restricted cubic splines with
five knots.
Data were analysed using Stata statistical software (version
15; StataCorp LP), and a P value <0·05 was considered sta-
tistically significant.
Results
A total of 160 725 men and women were invited to participate in
the Diet Cancer and Health cohort study and 57 053 accepted.
We excluded 1805 participants because they had a diagnosis
of cancer (n 569), PAD (n 330) or chronic kidney disease (n 31)
before enrolment, or forwhom information on exposure or other
covariates was missing (n 960) (Fig. 1). Among the remaining
55 248 participants, we identified 950 participants who devel-
oped PAD during a median of 13·6 (95 % central range: 4·3–15·3)
years of follow-up. The incidence rate of PAD was 1·32 per 1000
person years.
Baseline characteristics of the participants with complete
information on covariates in the cohort and participants who
developed PAD during follow-up are presented in Table 1.
The median energy-adjusted dietary ALA intake in the cohort
was 1·76 g/d (95 % central range: 0·94–3·28).
Invited participants
n 160 725
Diet, Cancer and Health Cohort
n 57 053
Exclusions: 
- Prior cancer: 569
- Prior peripheral arterial disease: 330
- Prior chronic kidney insufficiency: 31
- Missing information on exposure 
and/or other covariates: 960
1805
Incident cases of peripheral arterial
disease
n 950
Study population
n 55 248
Fig. 1. Flowchart of participants in the Diet, Cancer and Health cohort and incident cases of peripheral artery disease identified during follow-up.
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In spline analyses including adjustment for sex and age (model
1A), we found a positive association between ALA intake and the
rate of PAD (online Supplementary Fig. S1). However,
in multivariable analyses including additional adjustment for
established risk factors for PAD (model 1B) a weak statistically
non-significant inverse U-shaped association between ALA intake
and the rate of PAD was observed (P= 0·339) (Fig. 2). Additional
adjustment for co-morbidities (model 2) also showed a weak
inverse U-shaped association between ALA intake and the rate
of PAD that was not statistically significant (P= 0·338) (online
Supplementary Fig. S2). In supplemental analyses, with additional
adjustment for dietary risk factors (model 3), we found a weak
inverse association to PAD above the median ALA intake, but
the overall association was not statistically significant different
from a horizontal line (P= 0·314) (online Supplementary Fig. S3).
Sensitivity analyses indicated that models with ALA intakemod-
elled as restricted cubic splines were robust when the location and
number of knots for the exposure of interest were modified.
Categorical analyses of the association between ALA intake in
quintiles and the rate of PAD are presented in Table 2. We found
similar patterns of associations in analyses of ALA intake in quin-
tiles and the rate of PAD as in the spline analyses. The individual
hazards in the second to fifth quintile were not statistically signifi-
cantly different from the reference in the first quintile in either of
the multivariable adjusted models. In supplemental analyses,
additional adjustment for myocardial infarction and/or ischae-
mic stroke before enrolment did not influence the observed
associations. Also, additional adjustment for use of hormone
substitution did not influence the observed associations (data
not shown).
Similar patterns of associations between ALA intake and the
rate of PAD were observed when the analyses were conducted
separately among men and women (online Supplementary
Table S2).
No evidence of a departure from the proportionality
assumption was observed in either of the models (data not
shown).
Discussion
In this large follow-up study, we found indications of a weak
inverse U-shaped association between ALA intake and the rate
of PAD in analyses including adjustment for established risk fac-
tors and indications of a weak inverse association between ALA
intake and the rate of PAD above the median intake in analyses
including adjustment for established risk factors and dietary
risk factors. However, none of these associations was statistically
significant. Given the relatively weak and statistically non-
significant associations, the present study suggests that dietary
intake of ALA is not appreciably associated with the risk of
PAD within this population of middle-aged Danish men and
women. It should be stressed that the present study did
not investigate the potential effect of a Mediterranean diet on
PAD risk, but the results may indicate that the possible protective
effect provided by the Mediterranean dietary pattern on PAD and
major cardiovascular events is unlikely to be ascribed to ALA
intake.
The present study had some limitations that should be men-
tioned. Participants were followed by linkage with nationwide
registries with very limited loss to follow-up, which limits the
potential of selection bias. Information on ALA intake was
obtained using a self-administered FFQ andmeasurement error
is inevitable, but because of the temporality in a follow-up
study, exposure measurement error probably occurred at ran-
dom, which generally leads to an underestimation of the true
association and loss of statistical power. The FFQ used in the
present study was not specifically developed to assess ALA
intake. Further, information on diet was only available at base-
line and changes in dietary habits during follow-up may have
occurred. Thus, repeated dietary measurements would have
been preferable to limit randommeasurement error and to cap-
ture potential changes in dietary habits over time. However,
diets of individuals tend to be relatively consistent over inter-
vals of several years(39). Information bias is unlikely to have
influenced the observed associations significantly because
Table 1. Baseline characteristics
(Medians and 2·5th, 97·5th percentiles; percentages)
Cohort (n 55 248) PAD cases (n 950)
Median
2·5th, 97·5th
percentiles Median
2·5th, 97·5th
percentiles
Sex (%)
Males 47·7 62·1
Females 52·3 37·9
Age at enrolment
(years)
56·1 50·5, 64·7 58·6 50·7, 64·9
Length of schooling (%)
≤7 years 32·7 48·0
8–10 years 46·2 40·2
>10 years 21·1 11·8
Smoking (%)
Never 35·4 4·8
Former 28·9 18·0
Current <15 g/d 13·0 19·0
Current 15–25 g/d 16·0 40·4
Current >25 g/d 6·8 17·7
Physical activity (%)
Inactive 10·8 16·3
Moderately inactive 30·4 32·0
Moderately active 24·2 21·2
Active 34·7 30·5
Waist circumference
(cm)
89·0 67·0, 115·0 91·3 68·8, 117·0
BMI (kg/m2) 25·5 19·6, 35·7 25·5 19·3, 34·7
Alcohol intake (g/d) 12·9 0·2, 81·0 16·5 0·0, 104·7
Co-morbidities (%)
Hypercholesterolaemia 7·4 13·8
Hypertension 16·1 27·8
Diabetes mellitus 2·0 10·7
Dietary factors
Total energy intake
(kJ)
8895·2 4937·2,
15 142·9
8749·6 4730·1,
15 537·0
Intake of fibre* 20·6 12·3, 31·9 19·3 11·1, 29·9)
Glycaemic load* 189·8 98·8, 333·3 182·7 93·5, 335·9
SFA* 28·7 16·4, 42·4 31·4 18·5, 44·2
MUFA* 28·1 16·3, 43·3 31·3 18·3, 46·0
Linoleic acid* 11·0 5·7, 20·1 11·4 6·2, 20·0
Long-chain n-3 PUFA* 0·7 0·1, 1·7 0·7 0·2, 1·8
α-Linolenic acid* 1·8 0·9, 3·3 1·9 1·0, 3·4
PAD, peripheral artery disease.
* Energy-adjusted intake.
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diagnoses of PAD were established and validated independent
of the dietary assessment.
Identification of PAD cases in the present study relied on reg-
istered discharge diagnosis of PAD and the vast majority of iden-
tified cases were symptomatic patients. PAD may be
underdiagnosed in the general population(40) and cases either
asymptomatic or not referred to hospitals were not included
in the present study. However, random misclassification of a
diagnosis of PAD may bias associations towards no association,
but because PAD risk in general was relatively low, such poten-
tial bias was probably minor. We included detailed information
on established risk factors for PAD in the analyses, but residual
confounding from known or unknown PAD risk factors may still
be of importance for the observed associations. The observed
association between ALA intake and the rate of PAD (model
1A) was weakened after adjustment for established risk factors
for PAD (model 1B). However, additional adjustment for history
of hypercholesterolaemia, hypertension and diabetes (model 2)
showed a similar pattern of association compared with model
1B, which may indicate that potential residual confounding from
these co-morbidities was not of major importance. Notably,
these co-morbidities may also be considered intermediates
P = 0·3390·50
0·60
0·70
0·80
0·90
1·00
1·10
1·20
1·30
1·40
H
az
ar
d 
ra
tio
s 
fo
r P
AD
1·25 1·75 2·25 2·75 3·250·00 0·25 0·50 0·75 1·00 1·50 2·00 2·50 3·00 3·50
Energy-adjusted ALA intake (g/d)
Fig. 2. Intake of α-linolenic acid (ALA) and the risk of incident peripheral artery disease (PAD). Themultivariable analyseswere conducted usingCox proportional hazard
regression including adjustment for established PAD risk factors (model 1B) with themedian intake of ALA as reference. The 20th, 40th, 60th and 80th percentiles of ALA
intake are shown with dotted lines. The shaded grey area indicates the 95 %CI of hazard ratios of PAD ___. The spline plot is shown for the 2·5–97·5 percentiles of ALA
intake.
Table 2. Quintiles of energy-adjusted α-linolenic acid (ALA) intake and risk for peripheral artery disease*
(Hazard ratios (HR) and 95 % confidence intervals)
Quintiles of ALA
intake
Cases
(n)
Model 1A† Model 1B‡ Model 2§ Model 3‖
HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI
<1·36 g/d 116 1 Reference 1 Reference 1 Reference 1 Reference
1·36–1·62 g/d 154 1·24 0·98, 1·58 1·08 0·85, 1·38 1·10 0·86, 1·40 0·98 0·75, 1·27
1·62–1·90 g/d 199 1·44 1·14, 1·83 1·14 0·91, 1·45 1·18 0·93, 1·49 0·99 0·76, 1·30
1·90–2·27 g/d 228 1·50 1·18, 1·90 1·10 0·87, 1·40 1·14 0·90, 1·45 0·92 0·69, 1·23
> 2·27 g/d 253 1·62 1·27, 2·05 1·05 0·83, 1·34 1·11 0·87, 1·41 0·88 0·65, 1·20
* Statistical analyses were conducted using Cox proportional hazard regression. All models were adjusted for sex by allowing baseline hazards among men and women to differ.
† Model 1A included baseline age.
‡Model 1B included the variables of model 1A and the following risk factors for peripheral artery disease: length of schooling, smoking, physical activity, waist circumference, BMI and
alcohol intake.
§Model 2 included the variables of model 1B and the following potential intermediate variables: self-reported history of hypercholesterolaemia and/or use of lipid-loweringmedication,
hypertension and/or use of antihypertensive medication and diabetes mellitus and/or use of insulin.
‖Model 3 included the variables of model 1B and the following potential dietary risk factors: total energy intake, intake of fibre, glycaemic load, and intake of SFA, MUFA, linoleic acid
and long-chain n-3 PUFA.
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and conditioning for these covariates could potentially introduce
collider stratification bias(39), which may bias associations in
either direction. In analyses including adjustment for established
PAD risk factors and dietary factors (model 3) that may influence
PAD risk, the observed association between ALA intake and the
rate of PADwas slightly lower comparedwithmodel 1B at higher
ALA intakes and residual confounding from dietary factors can-
not be excluded. However, adjustment for dietary factors may
introduce restrictions in the underlying dietary pattern that are
not comparable with the ordinary dietary pattern and analyses
with and without dietary covariates should not be directly com-
pared. Therefore, given the interpretational challenges of models
2 and 3, we consider model 1B as the most appropriate for
interpretation.
The Diet, Cancer and Health cohort only included native
Danish participants from selected areas in Denmark who had
survived until enrolment into the study without a previous diag-
nosis of cancer, chronic kidney disease or PAD, which may limit
the generalisability of the study results.
We decided to conduct the main analyses as sex-stratified
analyses by allowing baseline hazards among men and women
to differ(5,6). Thus, the hazard ratios from these analyses should
be interpreted as a weighted average of the association in men
and women. Previous studies have suggested that the endog-
enous conversion efficiency of ALA into LC n-3 PUFA may be
stimulated by sex hormones and is greater in women(10).
However, in sex-specific analyses, we found similar patterns
of association between ALA intake and the risk of PAD among
men and women. Almost 60 % of the female participants were
post-menopausal at baseline(21) and a potential higher conver-
sion efficiency of ALA mediated by female sex hormones may
therefore not be of major importance in this cohort. In supple-
mental analyses, additional adjustment for hormone substitution
at baseline also did not influence the observed associations.
A previous cross-sectional study including 422 cases reported
that ALA intake was associated with a lower odds of PAD(41).
Another cross-sectional study including 199 cases reported
that the content of ALA in erythrocytes was associated with
lower odds of lower limb disease(42), whereas two case-control
studies did not find any appreciably nor statistically significant
differences between circulating levels of ALA between cases
and controls(43,44). However, none of these studies included
detailed adjustment for risk factors of PAD and the results should
be interpreted with caution due to the risk of residual con-
founding and reverse causation (cross-sectional studies).
We used restricted cubic splines to evaluate the shape of
the association between ALA intake and the rate of PAD. ALA
can be further metabolised into LC n-3 PUFA and lipid signalling
molecules, which occurs in a complex biological pathway by
enzymes that may be influenced by a combination of several
factors including sex, genetics and background diet(45) that
potentially could influence disease risk in a non-linear manner.
Previous studies have suggested that high intakes of themajor
n-6 PUFA linoleic acid and LC n-3 PUFA may lower the conver-
sion efficiency of ALA into LC n-3 PUFA due to inhibition on
shared enzymes. The median intake of LC n-3 PUFA in
this cohort was 0·7 g/d, which was higher than that in cohort
studies reporting inverse associations between ALA intake and
CHD(15,16,18–20) and this may be of importance for our study
findings because a large study has suggested that ALA may
reduce CHD risk in particular when intake of LC n-3 PUFA is
low(17). However, further well-powered studies investigating
the role of genetics and intake of LC n-3 and n-6 PUFA on the
association between ALA and the risk of atherosclerotic CVD
are warranted.
In conclusion, dietary intake of ALA was not consistently
associated with the risk of incident PAD among Danish middle-
aged men and women.
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